William H Herman

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
    W H Herman
    University of Michigan, Ann Arbor, MI, USA
    Diabet Med 29:937-44. 2012
  2. ncbi Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes
    William H Herman
    University of Michigan, 1000 Wall Street, Room 6100 SPC 5714, Ann Arbor, Michigan 48105 1912, USA
    J Clin Endocrinol Metab 97:1067-72. 2012
  3. ncbi A controlled trial of value-based insurance design - The MHealthy: Focus on Diabetes (FOD) trial
    Alicen Spaulding
    Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
    Implement Sci 4:19. 2009
  4. ncbi Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, CA, USA
    BMC Public Health 7:308. 2007
  5. ncbi Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy
    William H Herman
    University of Michigan Medical School, Ann Arbor 48105, USA
    Endocr Pract 17:563-7. 2011
  6. ncbi Do race and ethnicity impact hemoglobin A1c independent of glycemia?
    William H Herman
    University of Michigan, Ann Arbor, Michigan 48109 5354, USA
    J Diabetes Sci Technol 3:656-60. 2009
  7. ncbi Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes
    William H Herman
    Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 94:1689-94. 2009
  8. ncbi A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    William H Herman
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0354, USA
    Diabetes Care 28:1568-73. 2005
  9. ncbi Underdiagnosis of peripheral neuropathy in type 2 diabetes
    William H Herman
    Department of Internal Medicine and Epidemiology, University of Michigan Health System, 1500 East Medical Center Drive, 3920 Taubman Center, Ann Arbor, MI 48109-0354, USA
    Diabetes Care 28:1480-1. 2005
  10. ncbi Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study
    William H Herman
    Michigan Diabetes Research and Training Center, Ann Arbor, MI 48109 0354, USA
    Am J Manag Care 11:273-8. 2005

Research Grants

  1. Michigan Diabetes Reseach and Training Center
    William Herman; Fiscal Year: 2007
  2. Michigan Diabetes Reseach and Training Center
    William Herman; Fiscal Year: 2007

Detail Information

Publications115 found, 100 shown here

  1. ncbi Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
    W H Herman
    University of Michigan, Ann Arbor, MI, USA
    Diabet Med 29:937-44. 2012
    ..The purpose of this study was to evaluate the performance of the MNSI in detecting distal symmetrical peripheral neuropathy in patients with Type 1 diabetes and to develop new scoring algorithms...
  2. ncbi Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes
    William H Herman
    University of Michigan, 1000 Wall Street, Room 6100 SPC 5714, Ann Arbor, Michigan 48105 1912, USA
    J Clin Endocrinol Metab 97:1067-72. 2012
    ..HbA1c must be used thoughtfully and in combination with traditional glucose criteria when screening for and diagnosing diabetes...
  3. ncbi A controlled trial of value-based insurance design - The MHealthy: Focus on Diabetes (FOD) trial
    Alicen Spaulding
    Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
    Implement Sci 4:19. 2009
    ..This program has the potential for broad dissemination to other employers and insurers wishing to improve the value of their health care spending...
  4. ncbi Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, CA, USA
    BMC Public Health 7:308. 2007
    ..Our understanding of social disparities in diabetes-related health behaviors is incomplete. The purpose of this study was to determine if having less education is associated with poorer diabetes-related health behaviors...
  5. ncbi Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy
    William H Herman
    University of Michigan Medical School, Ann Arbor 48105, USA
    Endocr Pract 17:563-7. 2011
    ..To compare outcomes in patients with type 2 diabetes initiating insulin lispro mix 75/25 (75% insulin lispro protamine suspension and 25% lispro) or insulin glargine therapy, stratified by baseline oral antihyperglycemic agent (OHA) use...
  6. ncbi Do race and ethnicity impact hemoglobin A1c independent of glycemia?
    William H Herman
    University of Michigan, Ann Arbor, Michigan 48109 5354, USA
    J Diabetes Sci Technol 3:656-60. 2009
    ..Even more important, it must be determined whether differences among individuals or groups correlate with susceptibility to complications or merely reflect variation in hemoglobin glycation...
  7. ncbi Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes
    William H Herman
    Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 94:1689-94. 2009
    ..Recent studies have reported hemoglobin A(1c) (A1c) differences across racial/ethnic groups. Our diverse population allows for further investigation of potential differences in measurements of glycemia...
  8. ncbi A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    William H Herman
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0354, USA
    Diabetes Care 28:1568-73. 2005
    ..To compare the efficacy and safety of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MDI) in older adults with insulin-treated type 2 diabetes and to assess treatment satisfaction and quality of life...
  9. ncbi Underdiagnosis of peripheral neuropathy in type 2 diabetes
    William H Herman
    Department of Internal Medicine and Epidemiology, University of Michigan Health System, 1500 East Medical Center Drive, 3920 Taubman Center, Ann Arbor, MI 48109-0354, USA
    Diabetes Care 28:1480-1. 2005
  10. ncbi Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study
    William H Herman
    Michigan Diabetes Research and Training Center, Ann Arbor, MI 48109 0354, USA
    Am J Manag Care 11:273-8. 2005
    ....
  11. ncbi Hemoglobin A1c for the diagnosis of diabetes: practical considerations
    William H Herman
    Department of Internal Medicine, University of Michigan, Michigan, USA
    Pol Arch Med Wewn 120:37-40. 2010
    ..Combining the use of HbA1c and plasma glucose measurements for the diagnosis of diabetes offers the benefits of each test and reduces the risk of systematic bias inherent in HbA1c testing alone...
  12. ncbi Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation
    William H Herman
    Departments of Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0354, USA
    Diabetes Care 26:683-7. 2003
    ..To evaluate the within-trial effect of losartan and conventional antihypertensive therapy (CT) compared with placebo and CT on the economic cost associated with end-stage renal disease (ESRD)...
  13. ncbi The economics of diabetes prevention
    William H Herman
    Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Brehm Tower, 1000 Wall Street SPC 5714, Ann Arbor, MI 48105, USA
    Med Clin North Am 95:373-84, viii. 2011
    ....
  14. ncbi Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs
    W H Herman
    Department of Internal Medicine, School of Public Health, University of Michigan, Ann Arbor
    J Reprod Med 44:33-8. 1999
    ..To describe and compare pregnancy outcomes, resource utilization and costs among women with diabetes who receive and do not receive preconception care...
  15. ncbi Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene
    W H Herman
    Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109 0354, USA
    Diabetes 46:1749-54. 1997
    ..The decrease in glucagon AUC and decreased suppression of glucagon AUC with hyperglycemia suggest that mutations in HNF-4alpha may lead to alpha-cell as well as beta-cell secretory defects or a reduction in pancreatic islet mass...
  16. ncbi Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lecture, 2006
    William H Herman
    Michigan Diabetes Research and Training Center, University of Michigan Health System, 3920 Taubman Center, Ann Arbor, MI 48109-0354, USA
    Diabetes Care 30:1912-9. 2007
  17. ncbi Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)
    Steven E Kahn
    Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA
    Diabetes Care 33:177-83. 2010
    ..In the short term, commonly prescribed antidiabetic agents have different effects on CRP; however, the long-term effects of those agents are unknown...
  18. ncbi Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT
    Steven E Kahn
    Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA
    Diabetes 60:1552-60. 2011
    ..Herein, we examine measures of β-cell function and insulin sensitivity from an oral glucose tolerance test (OGTT) over a 4-year period among the three treatments...
  19. ncbi Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study
    James W Albers
    Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Diabetes Care 33:1090-6. 2010
    ....
  20. ncbi Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD)
    Dori Bilik
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    Pharmacoepidemiol Drug Saf 19:715-21. 2010
    ..We compared CVD incidence, cardiovascular (CV), and all-cause mortality in type 2 diabetic patients treated with rosiglitazone or pioglitazone as their only TZD...
  21. ncbi Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program
    William H Herman
    Department of Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    Diabetes Care 30:2453-7. 2007
    ..We sought to examine racial and ethnic differences in A1C in individuals with impaired glucose tolerance (IGT)...
  22. ncbi Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT)
    Steven E Kahn
    Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington 98108, USA
    Diabetes Care 31:845-51. 2008
    ..The purpose of this study was to examine possible factors associated with the increased risk of fractures observed with rosiglitazone in A Diabetes Outcome Progression Trial (ADOPT)...
  23. ncbi DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history
    Rodica Pop-Busui
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
    Curr Diab Rep 10:276-82. 2010
    ..The lessons learned about the natural history of distal symmetrical polyneuropathy and cardiovascular autonomic neuropathy and the impact of glycemic control on neuropathy are discussed in this review...
  24. ncbi Preventive counseling among women with histories of gestational diabetes mellitus
    Catherine Kim
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 30:2489-95. 2007
    ..The purpose of this study was to examine the association between recall of recommendations for diabetes prevention and both health behaviors and screening among women with histories of gestational diabetes mellitus (GDM)...
  25. ncbi Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 35:1301-9. 2012
    ..To examine demographic, socioeconomic, and biological risk factors for all-cause, cardiovascular, and noncardiovascular mortality in patients with type 2 diabetes over 8 years and to construct mortality prediction equations...
  26. ncbi The effort required to achieve and maintain optimal glycemic control
    Elyse S Rosenthal
    University of Michigan, College of Literature, Arts and Sciences, Ann Arbor, MI, USA
    J Diabetes Complications 25:283-8. 2011
    ..Insulin therapy is most effective when dosage is frequently adjusted. We sought to evaluate the effort required to maintain A1C below 7% once attained in older patients with type 2 diabetes...
  27. ncbi The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age
    Susan L Johnson
    Department of Internal Medicine, Michigan Diabetes Research and Training Center, University of Michigan Health System, 1500 E. Medical Center Dr, 3920 Taubman Center, Ann Arbor, MI 48109-0354, USA
    Diabetes Care 28:307-11. 2005
    ..9 billion. CONCLUSIONS: Screening for type 2 diabetes every 3 years with an RPG cut point of 130 mg/dl or the multivariate equation provides good yield and minimizes false-positive screening tests and costs...
  28. ncbi Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 30:1736-41. 2007
    ..We sought to examine demographic, socioeconomic, and biological predictors of all-cause, cardiovascular, and noncardiovascular mortality in patients with diabetes...
  29. ncbi Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study
    Joyce M Lee
    300 NIB, Room 6E05, Campus Box 0456, Ann Arbor, MI 48109 0456, USA
    Diabetes Care 29:2427-32. 2006
    ..We sought to examine the distribution of insulin and homeostasis model assessment of insulin resistance (HOMA-IR) and associations of HOMA-IR with sex, race/ethnicity, age, and weight status, as measured by BMI, among U.S. adolescents...
  30. ncbi Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study
    Jasmanda H Wu
    University of Michigan, School of Public Health, Epidemiology, Ann Arbor, MI 48109, USA
    Ann Epidemiol 13:369-76. 2003
    ..CONCLUSIONS: Antidiabetic drugs appear to be useful in alleviating the decline in physical and cognitive functioning among older Mexican Americans with diabetes, especially for those with a longer duration of the disease...
  31. ncbi The direct medical cost of type 2 diabetes
    Michael Brandle
    Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan, Ann Arbor, USA
    Diabetes Care 26:2300-4. 2003
    ..The estimates presented in this model may be used to analyze the cost-effectiveness of interventions for type 2 diabetes...
  32. ncbi The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes
    Susan L Johnson
    Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    J Diabetes Complications 25:211-5. 2011
    ..To determine whether continuous subcutaneous insulin infusion (CSII) or multiple daily injections of insulin (MDI) are associated with improved glycemic variability...
  33. ncbi Thiazolidinediones and fractures: evidence from translating research into action for diabetes
    Dori Bilik
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 95:4560-5. 2010
    ..Thiazolidinedione (TZD) treatment has been associated with fractures. The purpose of this study was to examine the association between TZD treatment and fractures in type 2 diabetic patients...
  34. ncbi Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) study
    Catherine Kim
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    Diabetes Care 27:1529-34. 2004
    ..To examine the association between the organizational model and diabetes processes of care...
  35. ncbi Temporal trends in recording of diabetes on death certificates: results from Translating Research Into Action for Diabetes (TRIAD)
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 34:1529-33. 2011
    ..To determine the frequency that diabetes is reported on death certificates of decedents with known diabetes and describe trends in reporting over 8 years...
  36. ncbi The influence of maternal weight and glucose tolerance on infant birthweight in Latino mother-infant pairs
    Edith C Kieffer
    Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, MI 48109 1106, USA
    Am J Public Health 96:2201-8. 2006
    ..We assessed the influence of maternal anthropometric and metabolic variables, including glucose tolerance, on infant birthweight...
  37. ncbi Competing demands for time and self-care behaviors, processes of care, and intermediate outcomes among people with diabetes: Translating Research Into Action for Diabetes (TRIAD)
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 34:1180-2. 2011
    ..To determine whether competing demands for time affect diabetes self-care behaviors, processes of care, and intermediate outcomes...
  38. ncbi Physician perception of reimbursement for outpatient procedures among managed care patients with diabetes mellitus
    Catherine Kim
    Department of Medicine, Division of General Internal Medicine, University of Michigan, Ann Arbor, MI 48109 0429, USA
    Am J Manag Care 15:32-8. 2009
    ..To examine the association between physicians' reimbursement perceptions and outpatient test performance among patients with diabetes mellitus...
  39. ncbi The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
    William H Herman
    University of Michigan Health System, Ann Arbor, Michigan, USA
    Ann Intern Med 142:323-32. 2005
    ..LIMITATIONS: Simulation results depend on the accuracy of the underlying assumptions, including participant adherence. CONCLUSIONS: Health policy should promote diabetes prevention in high-risk individuals...
  40. ncbi Are health-related quality-of-life and self-rated health associated with mortality? Insights from Translating Research Into Action for Diabetes (TRIAD)
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    Prim Care Diabetes 3:37-42. 2009
    ..To determine if health-related quality-of-life and self-rated health are associated with mortality in persons with diabetes...
  41. ncbi Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 29:247-53. 2006
    ..Reporting of diabetes on death certificates has been stable over time. Death certificates underestimate the prevalence of diabetes among decedents and present a biased picture of the causes of death among people with diabetes...
  42. ncbi A computer simulation model of diabetes progression, quality of life, and cost
    Honghong Zhou
    University of Michigan Health System, 3920 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0354, USA
    Diabetes Care 28:2856-63. 2005
    ....
  43. ncbi Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications)
    Rodica Pop-Busui
    Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan 48105, USA
    J Am Coll Cardiol 61:447-54. 2013
    ....
  44. ncbi Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans
    Linda A Jaber
    Department of Pharmacy Practice, Wayne State University, MI, USA
    Diabetes Res Clin Pract 91:307-15. 2011
    ..To assess the feasibility and acceptability of a community-based, culturally-specific, Diabetes Prevention Program (DPP)-adapted, group lifestyle intervention in Arab-Americans...
  45. ncbi Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus
    Catherine Kim
    Division of General Internal Medicine, Department of Medicine, University of Michigan, Ann Arbor, USA
    Am J Public Health 96:1643-8. 2006
    ..We sought to determine rates and factors associated with screening for type 2 diabetes mellitus (DM) in women with a history of gestational diabetes mellitus...
  46. ncbi Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus
    Catherine Kim
    Department of Internal Medicine, Division of General Medicine, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 30:1102-6. 2007
    ..To compare the cost and time to diagnosis associated with several screening strategies for diabetes in women with histories of gestational diabetes mellitus (GDM)...
  47. ncbi Stress urinary incontinence in women with a history of gestational diabetes mellitus
    Catherine Kim
    Department of Internal Medicine, Division of General Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
    J Womens Health (Larchmt) 17:783-92. 2008
    ..The purpose of this study was to examine the prevalence of stress incontinence among women with hGDM and to examine its association with their current physical activity...
  48. ncbi Self-efficacy, social support, and associations with physical activity and body mass index among women with histories of gestational diabetes mellitus
    Catherine Kim
    Division of General Internal Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    Diabetes Educ 34:719-28. 2008
    ..To examine the associations between 2 potential facilitators of healthy behaviors (self-efficacy and social support), and both physical activity and body mass index (BMI) among women with histories of gestational diabetes mellitus (GDM)...
  49. ncbi Is physician gender associated with the quality of diabetes care?
    Catherine Kim
    Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    Diabetes Care 28:1594-8. 2005
    ..This study examines the association between physician gender and diabetes quality of care...
  50. ncbi Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD)
    Laura N McEwen
    Department of Internal Medicine Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 32:971-6. 2009
    ....
  51. ncbi Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC)
    Rodica Pop-Busui
    University of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology, Diabetes, Ann Arbor, MI, USA
    Circulation 119:2886-93. 2009
    ..We evaluated the effects of prior intensive insulin therapy on the prevalence and incidence of cardiac autonomic neuropathy (CAN) in former DCCT intensive and conventional therapy subjects 13 to 14 years after DCCT closeout...
  52. ncbi Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study
    Susan L Johnson
    Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, 48109, USA
    Diabetes Care 29:1733-8. 2006
    ..We examined factors associated with screening for albuminuria and initiation of ACE inhibitor or angiotensin receptor blocker (ARB) treatment in diabetic patients...
  53. ncbi Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study
    Catherine L Martin
    University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 33:2635-41. 2010
    ....
  54. ncbi Effect of a managed care disease management program on diabetes care
    Laura N McEwen
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    Am J Manag Care 15:575-80. 2009
    ..To determine if processes and outcomes of diabetes care improved between 2000 and 2006 in a managed care health plan with a comprehensive diabetes disease management program...
  55. ncbi A discrete-state discrete-time model using indirect observation
    Deanna J M Isaman
    Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA
    Stat Med 25:1035-49. 2006
    ..Next, we use simulation to investigate the finite-sample behaviour of our approach. Finally, we present two examples: a model of diabetic nephropathy and a model of cardiovascular disease in diabetes...
  56. ncbi Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans
    Nicole R Pinelli
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan, USA
    Diabetes Care 33:1373-5. 2010
    ..To describe 25-hydroxy vitamin D (25-OH-D) levels and examine associations between 25-OH-D levels and insulin resistance (IR), metabolic syndrome (MS), and glucose intolerance in Arab Americans...
  57. ncbi Impact of diabetes on cognitive function among older Latinos: a population-based cohort study
    Jasmanda H Wu
    University of Michigan, School of Public Health, Department of Epidemiology, 611 Church St, Ann Arbor, MI 48104, USA
    J Clin Epidemiol 56:686-93. 2003
    ..10, 95% CI=-0.32, 0.11). CONCLUSIONS: More diabetic complications were associated with major cognitive decline among diabetic subjects. Research on long-term impact of treatment for type 2 diabetes is warranted...
  58. ncbi Opportunistic screening for diabetes in routine clinical practice
    Mark W Ealovega
    Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan Health System, Ann Arbor, Michigan 48109-0354, USA
    Diabetes Care 27:9-12. 2004
    ..Interventions are needed to help physicians recognize and provide appropriate follow-up for patients with potentially abnormal random glucose levels...
  59. ncbi The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population
    Laura N McEwen
    Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Health System, 1500 E Medical Center Dr 3920 Taubman Center, Ann Arbor, MI 48109 5354, USA
    Obes Surg 20:919-28. 2010
    ..Its long-term cost effectiveness appears to depend on the natural history and cost of late postsurgical complications and the natural history and cost of untreated morbid obesity...
  60. ncbi Physician compensation from salary and quality of diabetes care
    Catherine Kim
    Division of General Internal Medicine, Department of Internal Medicine and Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA
    J Gen Intern Med 22:448-52. 2007
    ..To examine the association between physician-reported percent of total compensation from salary and quality of diabetes care...
  61. ncbi Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study
    Eve A Kerr
    Veterans Affairs Ann Arbor Healthcare System, Center for Practice Management and Outcomes Research, and University of Michigan, Ann Arbor, Michigan 48113 0170, USA
    Ann Intern Med 141:272-81. 2004
    ..No studies have compared care in the Department of Veterans Affairs (VA) with that delivered in commercial managed care organizations, nor have studies focused in depth on care comparisons for chronic, outpatient conditions...
  62. ncbi Improving diabetes processes of care in managed care
    Liza L Ilag
    Department of Internal Medicine, University of Michigan and the Michigan Diabetes Research and Training Center, Ann Arbor, Michigan, USA
    Diabetes Care 26:2722-7. 2003
    ..To evaluate the impact of systematic patient evaluation and patient and provider feedback on the processes and intermediate outcomes of diabetes care in Independent Practice Association model internal medicine practices...
  63. ncbi Community-based screening for diabetes in Michigan
    Bahman P Tabaei
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan 48109-0354, USA
    Diabetes Care 26:668-70. 2003
    ....
  64. ncbi Valuing health-related quality of life in diabetes
    J Todd Coffey
    Department of Biostatistics, University of Michigan, Ann Arbor 48109, USA
    Diabetes Care 25:2238-43. 2002
    ..The health utility scores provided should facilitate studies of the health burden of diabetes and the cost-utility of alternative strategies for the prevention and treatment of diabetes...
  65. ncbi Preconception care in managed care: the translating research into action for diabetes study
    Catherine Kim
    Department of Internal Medicine, University of Michigan, Ann Arbor, Mich, USA
    Am J Obstet Gynecol 192:227-32. 2005
    ..89-0.99) and BMI (kg/m2) (0.96, 95% CI 0.93-0.99) remained significant predictors of family planning counseling. CONCLUSIONS: Preconception counseling rates for diabetic women are low and associated with younger age and lower BMI...
  66. ncbi Does diabetes care compete with the provision of women's preventive care services?
    Bahman P Tabaei
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
    Diabetes Care 28:2644-9. 2005
    ..Care for chronic diseases may compete with preventive health care. To test this hypothesis, we examined the association between diabetes-related processes of care and preventive care in women...
  67. ncbi Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes
    Steven E Kahn
    Department of Internal Medicine, Division of Metbolism, Endocrinology and Nurtrition, VA Puget Sound Health Care System, 151, 1660 S Columbian Way, Seattle, WA 98108, USA
    Diabetes 55:2357-64. 2006
    ..Further, for CRP and fibrinogen this relationship is determined by body adiposity and not by insulin sensitivity or glucose control...
  68. ncbi Validation of a type 2 diabetes screening tool in rural Honduras
    Evan C Milton
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA
    Diabetes Care 33:275-7. 2010
    ..To validate a low-cost tool for identifying diabetic patients in rural areas of Latin America...
  69. ncbi The epidemiology of diabetes and its risk factors among Chaldean Americans
    Suha Al-Oballi Kridli
    Oakland University School of Nursing, Rochester, Michigan, USA
    Ethn Dis 15:S1-30-1. 2005
  70. ncbi The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs
    David P Nau
    Center for Medication Use, Policy and Economics, Department of Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, Mich 48109 1065, USA
    Am J Manag Care 10:118-23. 2004
    ..The trends in drug and total expenditures for diabetes patients also were examined...
  71. ncbi Are primary care physicians more likely to record diabetes on death certificates?
    Laura N McEwen
    Department of Internal Medicine Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 31:508-10. 2008
  72. ncbi An epidemiologic profile of children with diabetes in the U.S
    Joyce M Lee
    Division of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI 48109-0456, USA
    Diabetes Care 29:420-1. 2006
  73. ncbi Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006
    Catherine Kim
    Departments of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 33:780-5. 2010
    ..Iron deficiency has been reported to elevate A1C levels apart from glycemia. We examined the influence of iron deficiency on A1C distribution among adults without diabetes...
  74. ncbi Referral management and the care of patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) study
    Catherine Kim
    Division of General Internal Medicine, Department of Medicine, University of Michigan, Ann Arbor, Mich, USA
    Am J Manag Care 10:137-43. 2004
    ..To examine the effect of referral management on diabetes care...
  75. ncbi Impact of a critical pathway on inpatient management of diabetic ketoacidosis
    Liza L Ilag
    Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Michigan, 3920 Taubman Center, Ann Arbor, MI 48109 0354, USA
    Diabetes Res Clin Pract 62:23-32. 2003
    ..We conclude that implementation of a DKA critical pathway reduced practice variation and was associated with shorter LOS and a trend toward decreased cost. Some processes of care were improved but many require additional interventions...
  76. ncbi Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic states
    Stefan S Fajans
    Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Health System, Ann Arbor, MI 48106, USA
    Metabolism 60:86-91. 2011
    ..A combination of A1C and plasma glucose determinations, where necessary, is recommended for diagnosis or screening of diabetes or IGT...
  77. ncbi Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus
    Catherine Kim
    Department of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA
    Diabetes Care 34:1949-51. 2011
    ..Use of hemoglobin A(1c) (A1C) might increase testing. The association between A1C and glucose has not been examined in women with histories of GDM...
  78. ncbi Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?
    Joyce M Lee
    Division of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI, USA
    J Pediatr 158:947-952.e1-3. 2011
    ..To compare test performance of hemoglobin A1c (HbA1c) for detecting diabetes mellitus/pre-diabetes for adolescents versus adults in the United States...
  79. ncbi Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?
    James W Albers
    DCCT EDIC Research Group, Box DCCT EDIC, Bethesda, MD 20892, USA
    Diabetes Care 30:2613-8. 2007
    ..We sought to evaluate the prevalence of subclinical neuropathy in intensive and conventional treatment groups at completion of the Diabetes Control and Complications Trial (DCCT)...
  80. ncbi Does childhood overweight, parental perception of overweight, or family history of diabetes mellitus increase parental perception of type 2 diabetes risk for their child?
    Joyce M Lee
    Division of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI 48109 5456, USA
    J Pediatr Endocrinol Metab 23:267-70. 2010
    ..To evaluate factors that influence parental perception of diabetes mellitus risk for their child...
  81. ncbi Comparison of three methods for diabetes screening in a rural clinic in Honduras
    John D Piette
    VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States
    Rev Panam Salud Publica 28:49-57. 2010
    ..To evaluate two alternatives to the fasting plasma glucose (FPG) test for diabetes screening in Latin America...
  82. ncbi Impact of maternal nativity on the prevalence of diabetes during pregnancy among U.S. ethnic groups
    E C Kieffer
    School of Public Health, University of Michigan, Ann Arbor, USA
    Diabetes Care 22:729-35. 1999
    ..This study examines the impact of maternal nativity (birthplace) on the overall prevalence of diabetes during pregnancy and among 15 racial and ethnic groups in the U.S...
  83. ncbi Getting heavier, younger: trajectories of obesity over the life course
    J M Lee
    Division of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI 48109 5456, USA
    Int J Obes (Lond) 34:614-23. 2010
    ..Such trends may have implications for the prevalence of obesity-associated conditions among population subgroups, including type 2 diabetes...
  84. ncbi Physicians' participatory decision-making and quality of diabetes care processes and outcomes: results from the triad study
    M Heisler
    Veterans Affairs Center for Practice Management and Outcomes Research, VA Ann Arbor Health System, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    Chronic Illn 5:165-76. 2009
    ..We examined whether physicians' diabetes-specific treatment PDM preferences as well as their self-reported practices are associated with the quality of diabetes care their patients receive...
  85. ncbi Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study
    Jasmanda H Wu
    Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor 48109, USA
    Diabetes Care 26:314-9. 2003
    ..CONCLUSIONS: There was lower baseline functional status and a more rapid decline in functional status among older Mexican Americans with diabetes versus those without diabetes...
  86. ncbi A multivariate logistic regression equation to screen for diabetes: development and validation
    Bahman P Tabaei
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
    Diabetes Care 25:1999-2003. 2002
    ....
  87. ncbi Does microalbuminuria predict diabetic nephropathy?
    B P Tabaei
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0354, USA
    Diabetes Care 24:1560-6. 2001
    ....
  88. ncbi Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications
    W H Herman
    University of Michigan Medical Center, Ann Arbor 48109 0354, USA
    Diabet Med 15:1045-51. 1998
    ..Ocular conditions, blindness, and neuropathy were prevalent in the non-diabetic population. The microvascular and neuropathic complications of diabetes are a major clinical and public health problem in Egypt...
  89. ncbi A multivariate logistic regression equation to screen for dysglycaemia: development and validation
    B P Tabaei
    Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109-0354, USA
    Diabet Med 22:599-605. 2005
    ....
  90. ncbi Glycemia and the quality of well-being in patients with diabetes
    B P Tabaei
    Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
    Qual Life Res 13:1153-61. 2004
    ..The QWB-SA may be an appropriate measure to assess the health burden of hyperglycemia...
  91. ncbi Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice
    S Vijan
    Division of General Internal Medicine, University of Michigan, Ann Arbor, USA
    J Gen Intern Med 12:567-80. 1997
    ..Implementation of these practices has the potential to significantly improve quality of life and increase life expectancy in patients with type II diabetes mellitus...
  92. ncbi Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus
    Frederick B Dong
    Battelle, Centers for Public Health Research and Evaluation, Seattle, Washington, USA
    Pharmacoeconomics 22:1015-27. 2004
    ..This conclusion is sensitive to the extent that ACE inhibitors delay onset of microalbuminuria. Other factors such as the patient's age and glycaemic level must be considered when deciding to initiate early treatment...
  93. ncbi Lifestyle intervention to prevent diabetes: intensive and cost effective
    Judith Wylie-Rosett
    Division of Health Behavior and Nutrition, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, New York, USA
    Curr Opin Lipidol 17:37-44. 2006
    ..Although there is more to be learned about effective strategies in clinical practice, it seems clear that the intervention needs to incorporate individualization and long-term interaction with trained facilitators...
  94. ncbi Epidemiology of diabetes among Arab Americans
    Linda A Jaber
    Department of Pharmacy Practice, Wayne State University, Detroit, Michigan 48201, USA
    Diabetes Care 26:308-13. 2003
    ..To examine the prevalence of diabetes and glucose intolerance by age and sex in the Arab-American community of Dearborn, Michigan...
  95. ncbi The association between clinical care strategies and the attenuation of racial/ethnic disparities in diabetes care: the Translating Research Into Action for Diabetes (TRIAD) Study
    O Kenrik Duru
    David Geffen School of Medicine, University of California, Los Angeles, California 90024, USA
    Med Care 44:1121-8. 2006
    ..We sought to determine whether greater implementation of clinical care strategies in managed care is associated with attenuation of known racial/ethnic disparities in diabetes care...
  96. ncbi Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults
    Thomas J Hoerger
    Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Rd, P O Box 12194, Research Triangle Park, NC 27709, USA
    Diabetes Care 30:2874-9. 2007
    ..To estimate the cost-effectiveness of screening overweight and obese individuals for pre-diabetes and then modifying their lifestyle based on the Diabetes Prevention Program (DPP)...
  97. ncbi A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes
    Giancarlo Viberti
    Guy s, King s, and St Thomas School of Medicine, King s College, London, U K
    Diabetes Care 25:1737-43. 2002
    ....
  98. ncbi Microalbuminuria in the US population: third National Health and Nutrition Examination Survey
    Camille A Jones
    Division of Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA, 02215, USA
    Am J Kidney Dis 39:445-59. 2002
    ..MA is common, even among persons without diabetes or hypertension. Age, sex, race/ethnicity, and concomitant disease contribute to the variability of MA prevalence estimates...
  99. ncbi Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, Calif, and Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, USA
    Am J Public Health 98:365-70. 2008
    ..We assessed educational disparities in smoking rates among adults with diabetes in managed care settings...
  100. ncbi Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A
    Laurence Kennedy
    Division of Endocrinology, Department of Medicine, Shands Hospital at the University of Florida, Gainesville, Florida 32610, USA
    Diabetes Care 29:1-8. 2006
    ..The objective of this study was to assess the impact of active versus usual monitoring of algorithmic insulin titration and point-of-care (POC) versus laboratory HbA1c (A1C) measurement on glycemic control in primary care...
  101. ncbi Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
    Steven E Kahn
    Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle 98108, USA
    N Engl J Med 355:2427-43. 2006
    ..The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known...

Research Grants3

  1. Michigan Diabetes Reseach and Training Center
    William Herman; Fiscal Year: 2007
    ..4. Recruit, train, motivate and retain an effective workforce of basic, clinical, epidemiologic, and health services investigators and health care providers in the areas of diabetes, endocrinology and metabolism. ..
  2. Michigan Diabetes Reseach and Training Center
    William Herman; Fiscal Year: 2007
    ..4. Recruit, train, motivate and retain an effective workforce of basic, clinical, epidemiologic, and health services investigators and health care providers in the areas of diabetes, endocrinology and metabolism. ..